 mg/dL, aggressive
therapy to lower LDL
cholesterol levels with
atorvastatin (10-80 mg/dL),
with a target LDL level
of <2.6 mmol/L
(ideally <2.0 mmol/L), and
antihypertensive therapy
with amlodipine (5-10 mg/
dL) and losartan (50-100 mg/
dL) to lower the BP to a
target level of <140/90 mm
Hg, and hydrochlorothiazide
(12.5 mg/dL) was added if the
target BP was not achieved

Lin et al,2 2016
Taiwan

(A) 15
(B) 25

(A) 68.8
(B) 71.4

(A) 73
(B) 84

NR

(A) HTN 80%, DM 47%,
hypercholesterolemia
60%, smoking 33%, AF
6.6%
(B) HTN 80%, DM 36%,
hypercholesterolemia
68%, smoking 36%, AF 0%

Aggressive medical treatment
(dual antiplatelets if
tolerated or at least 1
antiplatelet, statin therapy
goal of LDL <100 mg/dL, DM
treatment goal of
HbA1c <7%, HTN treatment
goal of SBP of <140 mm Hg,
smoking cessation

Reiff et al, 20191
(SPACE-2 trial)
Germany

(A) 113
(B) 400

(A) 68
(B) 70

(A) 87
(B) 73.5

(A) 27
(B) 27

(A) HTN 90.3%, DM 35.4%,
CAD 35.4%,
hypercholesterolemia
80.5%, Current smoker
21.2%
(B) HTN 89.2%, DM 27.7%,
CAD 35.5%,
hypercholesterolemia
79